HDAC7 acts as an astrocytic mediator of Aβ pathology that directly engages IKK to drive astrocyte neurotoxicity and neurodegeneration in Alzheimer’s disease
Open Access
- 22 June 2026
- journal article
- research article
- Published by Springer Nature in Alzheimer's Research & Therapy
- Vol. 18 (1)
Abstract
Background: Astrocytes undergo reactive transformations in response to pathological stimuli and play a critical role in neuronal loss associated with Alzheimer’s disease (AD). However, the intrinsic mechanisms through which astrocytes detect amyloid-β (Aβ) pathology and develop neurotoxic properties remain inadequately understood. The dysregulation of class IIa Histone deacetylases (HDACs) has been implicated in astrocyte dysfunction under pathological conditions. This study aims to elucidate the role of HDAC7 as an astrocytic mediator of Aβ that drives the formation of neurotoxic reactive astrocytes, and to propose HDAC7 as a potential therapeutic target for mitigating neuronal loss and cognitive deficits in AD. Methods: We examined HDAC7 expression in APP/PS1 mice of varying ages using RT-qPCR, Western blotting, and immunostaining analysis. Astrocyte-specific HDAC7 overexpression and knockdown were achieved through adeno-associated virus (AAV) delivery (GfaABC1D promoter) in wild-type (WT) and APP/PS1 mice, followed by behavioral tests, immunostaining, RT-qPCR, and RNA-seq. Mechanistic studies were conducted using primary astrocytes derived from WT and Hdac7 flx/flx mice, employing co-immunoprecipitation, Western blotting, and neuron viability assays. Pharmacological inhibition of HDAC7 in APP/PS1 mice was performed via intraperitoneal injection of TMP195, and the effects on neurotoxic reactive astrocytes, neuronal and synaptic loss, and behavioral performance were measured. Results: HDAC7 was selectively upregulated in plaque-adjacent astrocytes in APP/PS1 mice. Overexpression of HDAC7 specifically in astrocytes was sufficient to induce a neurotoxic transcriptional profile, neuronal loss, and cognitive deficits in both WT and young APP/PS1 mice. Mechanistically, upon Aβ stimulation, the upregulated HDAC7 directly interacted with and deacetylated IKKα and IKKβ, resulting in the activation of IKK, translocation of NF-κB to the nucleus, and subsequent expression of neurotoxic genes. This neurotoxic conversion was dependent on IKK activity, as IKK inhibition nullified the effects in astrocytes overexpressing HDAC7. Conversely, astrocytic HDAC7 knockdown or treatment with TMP195 attenuated IKK-NF-κB signaling, reduced the presence of neurotoxic reactive astrocytes, and rescued neurodegeneration and cognitive deficits in APP/PS1 mice. Conclusions: HDAC7 acts as an intrinsic effector within astrocytes, responding to Aβ pathology and converting astrocytes into a neurotoxic state through direct interaction with IKK. Targeting HDAC7 presents a promising strategy for astrocyte-directed therapeutic interventions in Alzheimer’s disease.Keywords
Funding Information
- National Natural Science Foundation of China (82101493)
- National Natural Science Foundation of China (82474227)
- Basic and Applied Basic Research Foundation of Guangdong Province (2025A1515012551)
- Shenzhen Science and Technology Research and Development Funds (JCYJ20240813141825034)
- Science, Technology and Innovation Commission of Shenzhen Municipality (20231121103959001)
- Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions (2023SHIBS0003)
This publication has 60 references indexed in Scilit:
- The multifaceted roles of the transcription factor SP1 in the pathogenesis of Alzheimer's disease: From molecular regulation to therapeutic targetsAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2026
- GADD45G operates as a pathological sensor orchestrating reactive gliosis and neurodegenerationNeuron, 2025
- An astrocyte BMAL1-BAG3 axis protects against alpha-synuclein and tau pathologyNeuron, 2023
- Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer’s diseaseNeuron, 2022
- Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson’s diseaseBrain, Behavior, and Immunity, 2022
- Histone deacetylase 5 deacetylates the phosphatase PP2A for positively regulating NF-κB signalingJournal of Biological Chemistry, 2021
- Behaviorally consequential astrocytic regulation of neural circuitsNeuron, 2020
- Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunitiesMedicinal Research Reviews, 2020
- NFκB-Activated Astroglial Release of Complement C3 Compromises Neuronal Morphology and Function Associated with Alzheimer’s DiseaseNeuron, 2015
- Differential SUMOylation of LXRα and LXRβ Mediates Transrepression of STAT1 Inflammatory Signaling in IFN-γ-Stimulated Brain AstrocytesMolecular Cell, 2009